" class="no-js "lang="en-US"> Jeff Eidel - Medtech Alert
Saturday, September 20, 2025
Jeff Eidel

Jeff Eidel

About Jeff Eidel

Jeff Eidel will join PacBio as Chief Commercial Officer in August 2022, where he will manage all commercial activities including global sales, marketing and customer support.

Jeff brings 24 years of broad leadership & executive experience to PacBio, most recently holding the role of Chief Executive Officer at Cradle Genomics, a cell-based prenatal testing company in San Diego.  Prior to joining Cradle, Jeff was the Head of Corporate & Business Development at Illumina. Jeff joined Illumina in 2006 and held various Commercial, Corporate & Business Development and Finance leadership roles within the company, as well as serving as the General Manager of Illumina’s Madison, Wisconsin site after Illumina’s acquisition of Epicentre Biotechnologies.   Jeff held critical positions leading deals with several of the largest NGS customers and business partners, focusing on meeting customer needs, integrating acquisitions, catalyzing global growth, and introducing new products.

Prior to joining Illumina, Jeff worked at KPMG LLP, Corillian Corporation and Inovio Pharmaceuticals in several finance roles.

He earned degrees in Finance and Accounting from the University of Montana.

Related Story

PacBio Announces Appointment of Genomics Industry Veteran Jeff Eidel as Chief Commercial Officer

July 25 2022

PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the appointment of Jeff […]